Evolent Health and Centene Agree to Expanded Partnership for Oncology Specialty Care for Medicare Advantage Members
Centene will expand its use of Evolent Health's oncology solution across its Centene and WellCare Medicare Advantage (MA) members nationally.
- Centene will expand its use of Evolent Health's oncology solution across its Centene and WellCare Medicare Advantage (MA) members nationally.
- This agreement deepens the specialty care partnership between Centene and Evolent in the MA market.
- Ken Fasola, President of Centene Corporation said, "We continue to be impressed with Evolent's value-based specialty care platform and are excited about the announcement today to expand their oncology services into our Medicare Advantage markets later this year.
- "We are excited to expand our partnership with Centene to enable their goal of providing the most valuable tools to manage the quality and cost of oncology care for Medicare Advantage members nationally," stated Dan McCarthy, President of Evolent Health.